Password
This learning activity is for healthcare professionals only
Password
This learning activity is for healthcare professionals only
Mainstream genetic testing in patients with cancer is performed through the patient’s own oncology team during their existing oncology appointments, with support as required from the familial cancer centre (FCC) or genetics service.1
This learning activity for healthcare professionals takes a step-by-step approach to the mainstreaming process and its role in the management of patients with ovarian and/or breast cancer. It also outlines how oncology teams can implement mainstream genetic testing in their own oncology units.
The Mainstreaming Working Party for the COSA Familial Cancer Group recommends that all members of oncology teams who engage in mainstream genetic testing should complete this training module, or a similar training programme run by their local FCC or genetics service, prior to starting mainstream genetic testing.
This activity has been developed by a Steering Committee from the Mainstreaming Working Group for the Clinical Oncology Society of Australia (COSA) Familial Cancer Special Interest Group. The module has been supported by AstraZeneca through an independent third party agreement between the sponsor and COSA. Medical writing, digital development and in-kind support has been provided by The Med Collective and JHL Digital.
1.Rahman N. Clin Med 2014;14:436-439.